Delivery Order SPE2DB20D1100-SPE2DB25FA2Z4

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,430.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, with a performance period through January 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of Fingolimod 0.5 mg capsules. The contract, valued at $100,246.99, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a period of performance through October 17, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside....
This federal contract award of $62,452.57 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order with a completion date of November 19, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of providing pharmaceutical products and medical supplies to...
The federal contract award is for the delivery of 4566343663 FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty pharmaceutical product. The contract, valued at $47,195.60, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,526.70 Firm Fixed Price Delivery Order covers the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,485.98, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, with a completion date of November 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $17,619.60, is for the delivery of the pharmaceutical product Fingolimod 0.5mg in 30-count supplies. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00. This single-award IDC serves...
This is a $36,582.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fingolimod 0.5 mg capsules, a medication used for the treatment of multiple sclerosis. The contract has a ceiling value of $5,916.96 and a period of performance through April 14, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen...
This federal contract award is for the delivery of Fingolimod 0.5 mg capsules to the Defense Logistics Agency (DLA). The $51,351.06 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 2, 2023, with a completion date of May 3, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA2Z4
    Delivery Order

This federal contract award, valued at $3,253.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used for the treatment of certain medical conditions. The contract has an ultimate completion date of January 29, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

The contract award does not have a set-aside designation, indicating open competition. The prime contractor, Amerisourcebergen Drug Corp, is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002, and has a significant presence in providing medical products and services to federal government agencies, particularly within military and veterans' healthcare systems.

Generated 4/29/25, 10:04 AM